Early SARS-CoV-2 Tracheostomy

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
TracheostomyCharacteristics DiseaseMetabolic Disturbance
Interventions
PROCEDURE

Tracheostomy

We collected data from all tracheotomised patients including age, sex, existing comorbidities, duration indicators (length of endotracheal intubation, day of tracheotomy, length of stay in the intensive care unit (ICU), and total length of hospital stay), respirator weaning marked with YES / NO. From the laboratory parameters, we analyzed: lactate, urea, creatinine, potassium and D-dimer. They were collected at two time intervals, before tracheotomy and after tracheotomy.

Trial Locations (1)

72000

Cantonal Hospital, Zenica

All Listed Sponsors
lead

Cantonal Hospital Zenica

OTHER

NCT05520957 - Early SARS-CoV-2 Tracheostomy | Biotech Hunter | Biotech Hunter